NCT02910323

Brief Summary

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
116mo left

Started Jul 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Jul 2016Dec 2035

Study Start

First participant enrolled

July 12, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 22, 2016

Completed
19.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2035

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

19.4 years

First QC Date

September 15, 2016

Last Update Submit

February 13, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • HIT-6 scale

    Through study completion, an average of 5 years

  • Morningness-eveningness scale

    Through study completion, an average of 5 years

  • GAD-7 scale

    Through study completion, an average of 5 years

Secondary Outcomes (2)

  • Genetic markers

    Through study completion, an average of 5 years

  • Molecular biomarkers

    Through study completion, an average of 5 years

Study Arms (2)

Experimental group

Patients with a history of Cluster Headaches and other TACs, or Trigeminal Neuralgia.

Family/Healthy Controls

Healthy volunteer controls and family members may be enrolled for identification of genetic mutations.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cluster Headache and Trigeminal Neuralgia patients, family members and healthy volunteers

You may qualify if:

  • Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia.
  • Able to provide HIPAA authorization to share prior medical records/imaging.

You may not qualify if:

  • Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia.
  • Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
  • Inability or unwillingness of subject or legal guardian/representative to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

RECRUITING

Related Publications (1)

  • Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658. No abstract available.

    PMID: 23771276BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine, saliva, skin cells, other

MeSH Terms

Conditions

Cluster HeadacheParoxysmal HemicraniaTrigeminal Neuralgia

Condition Hierarchy (Ancestors)

Trigeminal Autonomic CephalalgiasHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTrigeminal Nerve DiseasesFacial NeuralgiaFacial Nerve DiseasesMouth DiseasesStomatognathic DiseasesCranial Nerve Diseases

Study Officials

  • Mark Burish, MD, PhD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rebecca Martinez, RN

CONTACT

Mark J Burish, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Neurosurgery

Study Record Dates

First Submitted

September 15, 2016

First Posted

September 22, 2016

Study Start

July 12, 2016

Primary Completion (Estimated)

December 1, 2035

Study Completion (Estimated)

December 1, 2035

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Locations